These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21138682)
41. HMGN2: An Antitumor Effector Molecule of γδT Cells. Chen J; Fan Y; Cui B; Li X; Yu Y; Du Y; Chen Q; Feng Y; Zhang P J Immunother; 2018 Apr; 41(3):118-124. PubMed ID: 29401165 [TBL] [Abstract][Full Text] [Related]
42. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation. Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189 [TBL] [Abstract][Full Text] [Related]
43. Cytotoxic function of gamma delta (gamma/delta) T cells against pamidronate-treated cervical cancer cells. Lertworapreecha M; Patumraj S; Niruthisard S; Hansasuta P; Bhattarakosol P Indian J Exp Biol; 2013 Aug; 51(8):597-605. PubMed ID: 24228383 [TBL] [Abstract][Full Text] [Related]
44. Gamma delta T cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface. Uchida R; Ashihara E; Sato K; Kimura S; Kuroda J; Takeuchi M; Kawata E; Taniguchi K; Okamoto M; Shimura K; Kiyono Y; Shimazaki C; Taniwaki M; Maekawa T Biochem Biophys Res Commun; 2007 Mar; 354(2):613-8. PubMed ID: 17250803 [TBL] [Abstract][Full Text] [Related]
45. Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells. Okamoto T; Yamada N; Tsujimura T; Sugihara A; Nishizawa Y; Ueda H; Kashiwamura S; Tsutsui H; Futani H; Maruo S; Okamura H; Terada N J Interferon Cytokine Res; 2004 Mar; 24(3):161-7. PubMed ID: 15035849 [TBL] [Abstract][Full Text] [Related]
46. Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate. Sugai S; Yoshikawa T; Iwama T; Tsuchiya N; Ueda N; Fujinami N; Shimomura M; Zhang R; Kaneko S; Uemura Y; Nakatsura T Int J Oncol; 2016 May; 48(5):1794-804. PubMed ID: 26936487 [TBL] [Abstract][Full Text] [Related]
47. Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells. Nakashima Y; Deie M; Yanada S; Sharman P; Ochi M Int J Oncol; 2005 Oct; 27(4):965-71. PubMed ID: 16142312 [TBL] [Abstract][Full Text] [Related]
48. Modulation of innate immunity by IL-18. Li W; Yamamoto H; Kubo S; Okamura H J Reprod Immunol; 2009 Dec; 83(1-2):101-5. PubMed ID: 19853308 [TBL] [Abstract][Full Text] [Related]
49. Transdifferentiation of human MNNG/HOS osteosarcoma cells into vascular endothelial cells in vitro and in vivo. Wang X; Xu W; Wang S; Yu F; Feng J; Wang X; Zhang L; Lin J Oncol Rep; 2017 Nov; 38(5):3153-3159. PubMed ID: 29048647 [TBL] [Abstract][Full Text] [Related]
50. Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells. Fernández L; Metais JY; Escudero A; Vela M; Valentín J; Vallcorba I; Leivas A; Torres J; Valeri A; Patiño-García A; Martínez J; Leung W; Pérez-Martínez A Clin Cancer Res; 2017 Oct; 23(19):5824-5835. PubMed ID: 28659311 [No Abstract] [Full Text] [Related]
51. [Effects of Mycobacterium tuberculosis antigen and anti-TCRγδ antibody on IL-17 production of human γδT cells in polarization culture]. Chen L; Xia H; Wang H; Sheng L; Xu Z; Sun Y; Tang J; Li B Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):226-30. PubMed ID: 25652865 [TBL] [Abstract][Full Text] [Related]
52. Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid. Yoshiyama A; Morii T; Ohtsuka K; Ohnishi H; Tajima T; Aoyagi T; Mochizuki K; Satomi K; Ichimura S Anticancer Res; 2016 Feb; 36(2):625-31. PubMed ID: 26851017 [TBL] [Abstract][Full Text] [Related]
53. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity. Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953 [TBL] [Abstract][Full Text] [Related]
54. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study. Uchiyama T; Sato N; Narita M; Yamahira A; Iwabuchi M; Furukawa T; Sone H; Takahashi M Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877 [TBL] [Abstract][Full Text] [Related]
55. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells. Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099 [TBL] [Abstract][Full Text] [Related]
56. Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells. Arkko S; Zlatev HP; Mönkkönen H; Räikkönen J; Benzaïd I; Clézardin P; Mönkkönen J; Määttä JA Cancer Lett; 2015 Feb; 357(1):279-285. PubMed ID: 25444923 [TBL] [Abstract][Full Text] [Related]
57. Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo. Nakazawa T; Nakamura M; Matsuda R; Nishimura F; Park YS; Motoyama Y; Hironaka Y; Nakagawa I; Yokota H; Yamada S; Tamura K; Takeshima Y; Omoto K; Tanaka Y; Ouji Y; Yoshikawa M; Tsujimura T; Nakase H J Neurooncol; 2016 Sep; 129(2):231-41. PubMed ID: 27393349 [TBL] [Abstract][Full Text] [Related]
58. Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2 Fowler DW; Copier J; Dalgleish AG; Bodman-Smith MD Cancer Immunol Immunother; 2017 Sep; 66(9):1205-1215. PubMed ID: 28501938 [TBL] [Abstract][Full Text] [Related]
59. Possible pathogenic engagement of soluble Semaphorin 4D produced by γδT cells in medication-related osteonecrosis of the jaw (MRONJ). Movila A; Mawardi H; Nishimura K; Kiyama T; Egashira K; Kim JY; Villa A; Sasaki H; Woo SB; Kawai T Biochem Biophys Res Commun; 2016 Nov; 480(1):42-47. PubMed ID: 27720716 [TBL] [Abstract][Full Text] [Related]
60. Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells. Açil Y; Arndt ML; Gülses A; Wieker H; Naujokat H; Ayna M; Wiltfang J J Craniomaxillofac Surg; 2018 Apr; 46(4):538-546. PubMed ID: 29454604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]